PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-34.02%
Revenue decline while VET shows 28.33% growth. Joel Greenblatt would examine competitive position erosion.
-5.43%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
-49.00%
Gross profit decline while VET shows 144.59% growth. Joel Greenblatt would examine competitive position.
-22.71%
Margin decline while VET shows 90.59% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
383.87%
G&A growth while VET reduces overhead. John Neff would investigate operational differences.
-100.00%
Marketing expense reduction while VET shows 0.00% growth. Joel Greenblatt would examine competitive risk.
-99.24%
Other expenses reduction while VET shows 0.00% growth. Joel Greenblatt would examine efficiency.
10.81%
Operating expenses growth less than half of VET's 296.29%. David Dodd would verify sustainability.
3.16%
Total costs growth less than half of VET's 7.27%. David Dodd would verify sustainability.
4.48%
Interest expense growth less than half of VET's 13.49%. David Dodd would verify sustainability.
-11.24%
D&A reduction while VET shows 22.22% growth. Joel Greenblatt would examine efficiency.
-70.93%
EBITDA decline while VET shows 65.29% growth. Joel Greenblatt would examine position.
-56.97%
EBITDA margin decline while VET shows 28.80% growth. Joel Greenblatt would examine position.
-134.64%
Operating income decline while VET shows 87.73% growth. Joel Greenblatt would examine position.
-152.50%
Operating margin decline while VET shows 46.29% growth. Joel Greenblatt would examine position.
65.10%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
-55.82%
Pre-tax income decline while VET shows 12.42% growth. Joel Greenblatt would examine position.
-136.16%
Both companies show margin pressure. Martin Whitman would check industry conditions.
125.44%
Tax expense growth above 1.5x VET's 46.66%. Michael Burry would check for concerning trends.
-438.75%
Both companies show declining income. Martin Whitman would check industry conditions.
-716.52%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-446.30%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-442.59%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
-0.79%
Share count reduction while VET shows 0.00% change. Joel Greenblatt would examine strategy.
-0.01%
Diluted share reduction while VET shows 0.00% change. Joel Greenblatt would examine strategy.